SonoScape Medical Corp.
SZSE:300633.SZ
45.25 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,013.857 | 2,120.252 | 1,762.649 | 1,444.598 | 1,163.082 | 1,253.854 | 1,226.849 | 989.07 | 719.357 | 685.827 | 639.724 | 592.242 | 484.248 |
| Cost of Revenue
| 729.349 | 684.238 | 584.041 | 471.206 | 390.271 | 435.276 | 369.596 | 313.294 | 251.826 | 255.076 | 235.766 | 231.567 | 209.144 |
| Gross Profit
| 1,284.508 | 1,436.013 | 1,178.608 | 973.392 | 772.81 | 818.578 | 857.253 | 675.776 | 467.53 | 430.751 | 403.958 | 360.675 | 275.103 |
| Gross Profit Ratio
| 0.638 | 0.677 | 0.669 | 0.674 | 0.664 | 0.653 | 0.699 | 0.683 | 0.65 | 0.628 | 0.631 | 0.609 | 0.568 |
| Reseach & Development Expenses
| 472.933 | 384.256 | 328.958 | 263.059 | 237.419 | 254.913 | 233.486 | 176.931 | 133.797 | 124.138 | 91.647 | 71.429 | 0 |
| General & Administrative Expenses
| 29.428 | 29.423 | 23.508 | 26.75 | 20.884 | 22.81 | 19.596 | 21.723 | 16.277 | 14.14 | 6.192 | 4.944 | 52.64 |
| Selling & Marketing Expenses
| 221.703 | 524.365 | 423.164 | 366.527 | 324.38 | 406.879 | 352.233 | 269.087 | 197.053 | 179.965 | 147.757 | 110.149 | 92.799 |
| SG&A
| 251.13 | 551.231 | 446.672 | 393.277 | 345.264 | 429.688 | 371.829 | 290.81 | 213.331 | 194.105 | 153.949 | 115.093 | 145.439 |
| Other Expenses
| 438.889 | 25.712 | -3.37 | 38.521 | -1.904 | 1.267 | -0.563 | -0.014 | 61.329 | 42.491 | 25.711 | 30.25 | 23.457 |
| Operating Expenses
| 1,162.952 | 961.199 | 770.593 | 654.229 | 571.097 | 680.078 | 581.183 | 452.579 | 379.398 | 349.25 | 272.702 | 212.29 | 149.754 |
| Operating Income
| 121.556 | 474.815 | 382.428 | 215.664 | -44.172 | 106.616 | 271.726 | 207.678 | 79.207 | 75.925 | 120.009 | 57.715 | 127.362 |
| Operating Income Ratio
| 0.06 | 0.224 | 0.217 | 0.149 | -0.038 | 0.085 | 0.221 | 0.21 | 0.11 | 0.111 | 0.188 | 0.097 | 0.263 |
| Total Other Income Expenses Net
| -1.367 | -0.984 | -0.486 | 38.547 | -0.366 | 1.076 | -0.371 | -0.014 | 61.329 | 42.491 | 25.71 | 30.25 | 23.457 |
| Income Before Tax
| 120.189 | 473.831 | 381.942 | 254.211 | -44.539 | 107.692 | 271.354 | 207.664 | 140.536 | 118.416 | 145.719 | 87.965 | 150.819 |
| Income Before Tax Ratio
| 0.06 | 0.223 | 0.217 | 0.176 | -0.038 | 0.086 | 0.221 | 0.21 | 0.195 | 0.173 | 0.228 | 0.149 | 0.311 |
| Income Tax Expense
| -22.208 | 19.394 | 12.131 | 6.966 | 1.725 | 6.155 | 18.731 | 17.641 | 10.109 | 12.544 | 13.967 | 17.316 | 20.877 |
| Net Income
| 142.397 | 454.437 | 369.808 | 247.245 | -46.263 | 101.537 | 252.624 | 190.023 | 130.427 | 105.871 | 131.752 | 70.649 | 129.941 |
| Net Income Ratio
| 0.071 | 0.214 | 0.21 | 0.171 | -0.04 | 0.081 | 0.206 | 0.192 | 0.181 | 0.154 | 0.206 | 0.119 | 0.268 |
| EPS
| 0.33 | 1.06 | 0.86 | 0.62 | -0.12 | 0.25 | 0.63 | 0.49 | 0.36 | 0.29 | 0.37 | 1.41 | 0 |
| EPS Diluted
| 0.33 | 1.05 | 0.86 | 0.62 | -0.12 | 0.25 | 0.63 | 0.49 | 0.36 | 0.29 | 0.37 | 1.41 | 0 |
| EBITDA
| 212.648 | 544.917 | 439.014 | 319.936 | 8.762 | 154.649 | 293.123 | 224.983 | 162.87 | 140.385 | 138.376 | 104.699 | 130.121 |
| EBITDA Ratio
| 0.106 | 0.257 | 0.249 | 0.221 | 0.008 | 0.123 | 0.239 | 0.227 | 0.226 | 0.205 | 0.216 | 0.177 | 0.269 |